Ma Hongzhe, Cai Min, Wang Huaning
Department of Psychiatry, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Front Psychiatry. 2021 Dec 14;12:792960. doi: 10.3389/fpsyt.2021.792960. eCollection 2021.
Emotional blunting is frequently reported by patients with major depressive disorder (MDD) and has been identified as one of the most prominent side effects of antidepressants leading to medication discontinuation. However, antidepressant-induced emotional blunting remains largely unexplored-there lacks a clinical definition of this condition, and no agreeing conclusion has been reached regarding its etiology. Current research suggests that the onset of diminished emotional response may be related to antidepressant dose, with higher doses being more likely to induce emotional blunting. Consequently, most clinicians either reduce the dose or switch to another drug when treating this symptom. Overall, more comprehensive clinical assessments or interviews specifically designed to evaluate antidepressant-induced emotional blunting in MDD patients are in need to elucidate the neuropsychological mechanisms behind this increasingly prevalent symptom.
重度抑郁症(MDD)患者经常报告有情感迟钝,并且情感迟钝已被确定为导致停药的抗抑郁药最突出的副作用之一。然而,抗抑郁药引起的情感迟钝在很大程度上仍未得到充分研究——目前缺乏对这种情况的临床定义,关于其病因也未达成共识。目前的研究表明,情感反应减弱的发作可能与抗抑郁药剂量有关,剂量越高越有可能诱发情感迟钝。因此,大多数临床医生在治疗这种症状时要么降低剂量,要么换用另一种药物。总体而言,需要更全面的临床评估或专门设计用于评估MDD患者抗抑郁药引起的情感迟钝的访谈,以阐明这种日益普遍的症状背后的神经心理学机制。